NIAID Restructures HIV Research Networks
The National Institute of Allergy and Infectious Diseases (NIAID) has chosen four clinical trial networks to lead HIV research over the next seven years.
NIAID selected the HIV Vaccine Trials Network, HIV Prevention Trials Network, AIDS Clinical Trials Group and the International Maternal Pediatric Adolescent AIDS Clinical Trials Network. The networks will work together to direct, coordinate and conduct NIH-funded global clinical research, as well as collaborating with NIAID and industry and nongovernment research organizations.
The institute also has awarded grants to 35 U.S. and international institutions selected as HIV clinical trial units (CTU). Each CTU will support up to eight clinical research sites and the CTUs will collectively support 101 clinical research sites in 18 countries across North America, South America, Africa and Asia.
NIAID and co-funding NIH institutes will provide up to $375.3 million in the first year to support the HIV networks.